SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

Share this page:


SeroTracker: a global SARS-CoV-2 seroprevalence dashboard



As the initial phase of the COVID-19 pandemic passes its peak in many countries, serological studies are becoming increasingly important in guiding public health responses. Antibody testing is crucial for monitoring the evolution of the pandemic, providing a more complete picture of the total number of people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than molecular diagnostic testing alone.

Go to the SeroTracker referenced in this article.

Date Last Updated (Year-Month-Day)



Arora, Rahul K., Abel Joseph, Jordan Van Wyk, Simona Rocco, Austin Atmaja, Ewan May, Tingting Yan, Niklas Bobrovitz, Jonathan Chevrier, Matthew P. Cheng, Tyler Williamson, and David L. Buckeridge. 2020. "SeroTracker: a global SARS-CoV-2 seroprevalence dashboard." The Lancet Infectious Diseases.


Free online